logo
Select company
Select metric
-8633.59%EBIT Margin
VS
Market
2
Sector
7
Industry
12
History
5
$ 4.03Close
$ 1.96 - $ 4.21 52-Week Range
Ticker Information

Ticker

VTGN

Company Name

VISTAGEN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

VISTAGEN THERAPEUTICS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VTGN - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -55.77M-8633.59%$ 646K
3/31/2025$ -51.41M-10578.4%$ 486K
12/31/2024$ -47.3M-6773.01%$ 698.3K
9/30/2024$ -39.56M-4517.15%$ 875.7K
6/30/2024$ -33.19M-3420.28%$ 970.4K
3/31/2024$ -29.36M-2759.21%$ 1.06M
12/31/2023$ -32.06M-3076.34%$ 1.04M
9/30/2023$ -35.48M-4377.06%$ 810.5K
6/30/2023$ -46.37M0%$ -359.7K
3/31/2023$ -59.24M0%$ -227.3K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VISTAGEN THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT % stands at -4682.96%.
  • Over the past 5 years, VISTAGEN THERAPEUTICS INC's average EBIT % has been -4307%.
  • The median EBIT % for VISTAGEN THERAPEUTICS INC during this period was -3863.58%
  • VISTAGEN THERAPEUTICS INC reached its highest EBIT % over the past 5 years at -1562.52%.
  • The lowest EBIT % recorded by VISTAGEN THERAPEUTICS INC in the same timeframe -10578.4%

VISTAGEN THERAPEUTICS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
RNXT : RENOVORX INC -1668.88%BTAI : BIOXCEL THERAPEUTICS INC -4022.24%ABVC : ABVC BIOPHARMA INC -715.36%COYA : COYA THERAPEUTICS INC -4973.22%AVTX : AVALO THERAPEUTICS INC -10946.03%ZTEK : ZENTEK LTD -945.83%ENTX : ENTERA BIO LTD -6378.31%INO : INOVIO PHARMACEUTICALS INC -48131.35%RPTX : REPARE THERAPEUTICS INC -43504.4%LEXX : LEXARIA BIOSCIENCE CORP -1849.39%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for VISTAGEN THERAPEUTICS INC is calculated as follows: EBIT [ $ -15.64M ] / Revenues [ $ 334K ]
(=) EBIT % [ -4682.96% ]

VTGN - EBIT Margin, Last 5 years

-10578.4%

Minimum

Mar 31, 2025

-1562.52%

Maximum

Jun 30, 2021

-4307%

Average

-3863.58%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%